Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program
Archives of Medical Research · 2026
DOI: 10.1016/j.arcmed.2025.103271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Medical Research, 2026. Verfasst von Ana C García-Ulloa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boehringer Ingelheim Corp USA, MSD, Novartis AG.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND AND AIMS: Overweight and obesity are prevalent conditions that contribute to significant health problems, including type two diabetes (T2D). Moderate weight loss improves metabolic control and cardiovascular risk. We aimed to identify the demographic and clinical characteristics of patients with T2D who experienced weight changes after a multidisciplinary intervention. METHODS: We analyzed 622 patients with complete 3-year follow-up information. Inclusion criteria were less than 5-years since diabetes diagnosis and an absence of disabling chronic complications. Descriptive statistics, ANOVA or Kruskal-Wallis tests were used for group comparisons, and logistic regression to identify predictors of weight change. RESULTS: Participants were 56.2% women, with an average age of 55.8 ± 10.5 years. 53% were overweight and 47% were obese at baseline. At 3-years, 35.5% lost weight, 33.9% maintained weight, and 30.5% gained weight; 16.6% achieved a normal weight. Patients who gained weight were younger than those who lost or maintained it (60 vs. 61 years, p = 0.04). Higher baseline HbA1c (OR 1.14, 95% CI 1.03-1.26, p = 0.008) and lower quality of life at three months (OR 1.48, 95% CI 0.95-2.28, p = 0.07) were associated with weight gain. Higher baseline BMI (OR 0.90, 95% CI 0.85-0.95, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Centro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Servicio de Oftalmología. Instituto de Oftalmología Fundación Conde de Val…
- Unidad de Epidemiología Clínica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: sergio.poncedeleonr@incmnsz.mx.
Förderung
- Boehringer Ingelheim Corp USA
- MSD
- Novartis AG
- Carlos Slim Foundation
- Novo Nordisk A/S
- National Council on Science and Technology
Zitieren
APA
García-Ulloa, A. C., Pérez-Peralta, L., Urbina-Arronte, L. E., Cárdenas-Fragoso, J. L., Landa-Anell, M. V., Melgarejo-Hernández, M. A., Gil, V. M., Ponce-de-León, S., Hernández-Jiménez, S., & Group of Study CAIPaDi (2026). Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program. Archives of Medical Research. https://doi.org/10.1016/j.arcmed.2025.103271
Vancouver
García-Ulloa AC, Pérez-Peralta L, Urbina-Arronte LE, Cárdenas-Fragoso JL, Landa-Anell MV, Melgarejo-Hernández MA, et al. Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program. Archives of Medical Research. 2026. doi:10.1016/j.arcmed.2025.103271
BibTeX
@article{GarcaUlloa2026,
author = {García-Ulloa, Ana C and Pérez-Peralta, Liliana and Urbina-Arronte, Luz E and Cárdenas-Fragoso, José L and Landa-Anell, Maria V and Melgarejo-Hernández, Marco A and Gil, Valeria Miranda and Ponce-de-León, Sergio and Hernández-Jiménez, Sergio and Group of Study CAIPaDi, Group of Study CAIPaDi},
title = {Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program},
journal = {Archives of Medical Research},
year = {2026},
doi = {10.1016/j.arcmed.2025.103271}
}
EUVIMED